Design Therapeutics, Inc.

DSGN · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$15,088$19,703$13,667$22,563
Short-Term Investments$190,882$196,573$216,007$222,914
Receivables$1,381$1,348$1,405$1,263
Inventory$0$0$0$0
Other Curr. Assets$1,678$2,170$2,565$1,300
Total Curr. Assets$209,029$219,794$233,644$248,040
Property Plant & Equip (Net)$2,741$3,092$3,404$3,626
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$427$427
Total NC Assets$2,741$3,092$3,831$4,053
Other Assets$0$0$0$0
Total Assets$211,770$222,886$237,475$252,093
Liabilities
Payables$1,913$1,013$3,180$2,186
Short-Term Debt$866$844$821$800
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$8,394$6,890$4,235$5,476
Total Curr. Liab.$11,173$8,747$8,236$8,462
LT Debt$877$1,102$1,320$1,534
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$877$1,102$1,320$1,534
Other Liabilities$0$0$0$0
Cap. Leases$877$1,946$2,141$2,334
Total Liabilities$12,050$9,849$9,556$9,996
Equity
Pref Stock$0$0$0$0
Common Stock$6$6$6$6
Retained Earnings-$281,009-$264,012-$244,929-$227,214
AOCI$358$305$450$475
Other Equity$480,365$476,738$472,392$468,830
Total Equity$199,720$213,037$227,919$242,097
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$211,770$222,886$237,475$252,093
Net Debt-$13,345-$17,757-$11,526-$20,229